HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
Sino Biopharm (01177) spent 13.372 million Hong Kong dollars on April 9th to repurchase 4 million shares.
09/04/2025
GMT Eight
Sino Biopharm (01177) announced that they will repurchase 4 million shares at a cost of 133.732 million Hong Kong dollars on April 9, 2025.
China Union (000036.SZ) plans to buy back company shares in the amount of 30 to 60 million yuan.
Shanghai Fosun Pharmaceutical (02196) spent 19.997 million yuan on April 9 to repurchase 848,400 shares of A shares.
RECOMMEND
Shenzhen Tongyi Industry (300538.SZ) controlling shareholder and one senior executive collectively reduced their shareholding by 2.52%.
20/04/2025
The two shareholders of Guangdong Tianhe Agricultural Means Of Production (002999.SZ) are planning to reduce their holdings by a total of not more than 1.2973 million shares.
20/04/2025
Significantly lower the target price for US stocks, Wall Street "torn reports", but still insist "will rise this year"
20/04/2025
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.
Contact:
[email protected]